Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Main Capital and Alfa eCare in connection with their strategic acquisition of Joliv
Mandate

Vinge has advised Main Capital and Alfa eCare in connection with their strategic acquisition of Joliv

June 16, 2020 Employment and Benefits Banking and Finance Intellectual Property M&A IT, Telecommunications and Outsourcing

The Alfa eCare group is a recognized eHealth software company, providing solutions to both public and private healthcare providers throughout Sweden.

Joliv provides a range of eHealth solutions servicing over 120 clients primarily in the elderly care market. Joliv’s solutions contribute to a safe and quality-assured work environment for care providers with reduced administration needs and more time for personal meetings with patients. The strategic merge creates a one-stop-shop offering for the Swedish care market helping care providers and municipalities to further improve the quality of care provision.
 
Vinge’s team consisted of Filip Öhrner, Kristina Ekberg, Jesper Lindvall, Jonathan Riddersholm, Ellen Åkerdahl Flygt (M&A), Ebba Svenburg (Employment), Karl-Hugo Engdahl (Agreements and GDPR/IT), Stojan Arnerstål (IPR), Mikael Ståhl, Axel Jansson (Banking and Finance), Carl Bruneheim and Nathalie Hughes (VDR Assistants).

 

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

 Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026